Orchestra Scientific, a cleantech company founded in 2017, is commercializing a specialized CO2 capture technology. The firm originated as a spin-off from the Institute of Chemical Research of Catalonia (ICIQ), leveraging research from Professor José Ramón Galán-Mascarós’s group. The core of its B2B is a patented material known as TAMOF-1, a type of metal-organic framework (MOF). This technology is designed to selectively capture carbon dioxide from a variety of gas streams, even at low concentrations where other methods may not be viable. The management team includes Cristina Sáenz de Pipaón as CEO, José Ramón Galán-Mascarós as Scientific Advisor, Elías Daura as CFO, José Luis León as CCO, and Álvaro Reyes as CTO. The company’s primary product is a membrane separation process that incorporates TAMOF-1 into thin, rollable plastic layers that can be installed in gas pipes and reactors. This system operates at ambient temperature and pressure, which can reduce electricity consumption by up to 25% compared to some available membranes. A key feature of TAMOF-1 is its ability to slow down and separate CO2 molecules from gas mixtures, a process particularly useful for biogas upgrading. By removing CO2 from biogas (typically a mix of methane and carbon dioxide), it produces biomethane that can be injected into the natural gas grid. Orchestra Scientific targets a diverse client base across multiple industries. In February 2025, the company announced it was testing its technology at the Familia Torres winery to concentrate CO2 produced during wine fermentation for reuse as an inert gas to prevent oxidation. This demonstrates the technology’s application in the agri-food sector. The company’s B2B model focuses on providing sustainable and cost-effective solutions for CO2 capture, aiming to help industries achieve zero or negative emissions by purifying CO2 for reuse or commercialization. Beyond biogas and fermentation, the company sees potential applications in larger, emission-intensive sectors like steel, cement, and petrochemicals. The material’s capabilities also extend to separating chiral intermediate compounds for the pharmaceutical industry. The company has been supported by several investors and accelerator programs, including InnoEnergy, Repsol Foundation, ESADE Creapolis, and Cleantech Camp. These partnerships have provided both capital and access to networks to refine its B2B model and scale its technology. Keywords: CO2 capture, carbon capture, metal-organic framework, MOF, TAMOF-1, biogas upgrading, biomethane, gas separation, membrane technology, cleantech, industrial emissions, circular economy, chemical separation, chiral separation, sustainable technology, flue gas treatment, carbon dioxide reuse, ICIQ spin-off, green technology, fermentation emissions
